Literature DB >> 30498203

Regulatory watch: European regulatory experience with advanced therapy medicinal products.

Lisbeth Barkholt1, Caroline Voltz-Girolt2, June Raine3, Tomas Salmonson1, Martina Schüssler-Lenz4.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30498203     DOI： 10.1038/nrd.2018.200

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  5 in total

1.  GMP Compliant Production of a Cryopreserved Adipose-Derived Stromal Cell Product for Feasible and Allogeneic Clinical Use.

Authors:  Mandana Haack-Sørensen; Ellen Mønsted Johansen; Lisbeth Drozd Højgaard; Jens Kastrup; Annette Ekblond
Journal:  Stem Cells Int       Date:  2022-06-20       Impact factor: 5.131

2.  In vivo generated human CAR T cells eradicate tumor cells.

Authors:  Shiwani Agarwal; Tatjana Weidner; Frederic B Thalheimer; Christian J Buchholz
Journal:  Oncoimmunology       Date:  2019-10-10       Impact factor: 8.110

Review 3.  Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies.

Authors:  Johannes P W Heidbuechel; Christine E Engeland
Journal:  J Hematol Oncol       Date:  2021-04-16       Impact factor: 17.388

4.  The Essential Need for a Validated Potency Assay for Cell-Based Therapies in Cardiac Regenerative and Reparative Medicine. A Practical Approach to Test Development.

Authors:  Lidia Gómez-Cid; Lilian Grigorian-Shamagian; Ricardo Sanz-Ruiz; Ana S de la Nava; Ana I Fernández; María Eugenia Fernández-Santos; Francisco Fernández-Avilés
Journal:  Stem Cell Rev Rep       Date:  2021-08-31       Impact factor: 5.739

Review 5.  Current landscape of clinical development and approval of advanced therapies.

Authors:  Carolina Iglesias-Lopez; Antonia Agustí; Antoni Vallano; Merce Obach
Journal:  Mol Ther Methods Clin Dev       Date:  2021-11-11       Impact factor: 6.698
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.